Company intelligence / Profile preview
Enoda Cellworks
Menlo Park, California, United Statesenodatech.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Enoda has not yet reported clinical results or advanced a candidate into human trials. Their focus is on engineering synthetic cytokine receptors using their MIMIC platform to overcome bottlenecks in current cell therapies such as persistence, resistance to immunosuppression in solid tumors, and enabling in vivo expansion.
- Therapeutic areas
- OncologyImmunologyOtherDermatologyInfectious Diseases
- Modalities
- Synthetic cytokine receptor therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Enoda Cellworks.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enoda Cellworks.